| Literature DB >> 33281350 |
Shah Jungy Ibna Karim1,2, Mahfuzul Islam2,3, Tahmina Sikder4, Rubaya Rubaya5, Joyanta Halder5,6, Jahangir Alam5.
Abstract
BACKGROUND AND AIM: Pigeon rearing has been gaining popularity for recent years. They are reared remarkably very close to the house of the owner. This activity, therefore, may pose potential threats for humans as well as other animals as pigeons may carry and spread different pathogens including drug-resistant bacteria. This study was conducted to explore the prevalence of Escherichia coli and Salmonella spp. as well as their antibiogram profile along with an association analysis.Entities:
Keywords: Escherichia coli; Salmonella spp; antimicrobial resistance; multidrug resistance; pigeon
Year: 2020 PMID: 33281350 PMCID: PMC7704316 DOI: 10.14202/vetworld.2020.2156-2165
Source DB: PubMed Journal: Vet World ISSN: 0972-8988
PCR primers with sequence.
| Primer | Sequence (5´-3´) | Size (bp) | Reference |
|---|---|---|---|
| GGGAGTAAAGTTAATC CTTTGCTC | 584 bp | [ | |
| TTCCCGAAGGCACATTCT | |||
| TTCCCGAAGGCACCAATC |
E. coli=Escherichia coli, PCR=Polymerase chain reaction
Total viable count, Escherichia coli count, and Salmonella spp. count in the swab samples of pigeon (n=40).
| Category | Sample type | Number of sample tested | Microorganism count (CFU/ml) | |||||
|---|---|---|---|---|---|---|---|---|
| Total viable | Total | Total | ||||||
| Number of positive (%) | Bacterial load | Number of positive (%) | Bacterial load | Number of positive (%) | Bacterial load | |||
| Sample from around Savar | ||||||||
| Household | Oral swab | 10 | 10 (100) | 1.6×105-3.8×109 | 6 (60) | 0.8×105-6.8×109 | 2 (20) | 1.6×105-1.8×105 |
| Cloacal swab | 10 | 10 (100) | 1.8×105-3.4×109 | 5 (50) | 3.1×106-5.7×109 | 2 (20) | 1.8×105-2.7×109 | |
| Sample from around Sher-e-Bangla Agricultural University, Dhaka | ||||||||
| Small farm | Oral swab | 10 | 10 (100) | 0.7×105-3.6×109 | 4 (40) | 1.7×109-6.5×109 | 4 (40) | 1.3×105-3.6×109 |
| Cloacal swab | 10 | 10 (100) | 1.3×105-3.6×109 | 6 (60) | 2.9×107-4.1×109 | 3 (30) | 1.3×105-2.5×109 | |
| Overall prevalence | 40 | 40 (100) | 21 (52.5) | 11 (27.5) | ||||
E. coli=Escherichia coli
Prevalence of E. coli and Salmonella spp. in oral and cloacal swabs of pigeons.
| Sources | Number of sample tested | Number of sample positive | Prevalence (%) |
|---|---|---|---|
| Oral swabs | 20 | 10 | 50 |
| Cloacal swabs | 20 | 11 | 55 |
| Overall | 40 | 21 | 52.5 |
| Oral swabs | 20 | 6 | 30 |
| Cloacal swabs | 20 | 5 | 25 |
| Overall | 40 | 11 | 27.5 |
E. coli=Escherichia coli
Prevalence of E. coli and Salmonella spp. in pigeons according to rearing system.
| Rearing system | Number of sample tested | Number of sample positive | Prevalence (%) |
|---|---|---|---|
| Household | 20 | 10 | 50 |
| Small farm | 20 | 11 | 55 |
| Overall | 40 | 21 | 52.5 |
| Household | 20 | 7 | 35 |
| Small farm | 20 | 4 | 20 |
| Overall | 40 | 11 | 27.5 |
E. coli=Escherichia coli
Figure-1Molecular detection and differentiation of Escherichia coli. About 584 bp fragment of 16s rRNA gene was amplified. Lane M: DNA marker, lane 1-5: Test sample, polymerase chain reaction (PCR) with 16E1+E2 primer, lane 6-10: Test sample, PCR with 16E1+16E3 primer.
Detection of E. coli by PCR.
| Source of | Number of isolate tested | Detection of different | ||
|---|---|---|---|---|
| 16E1+16E2 pathogenic | 16E1+16E3 non-pathogenic | 16E1+16E2+16E3 both pathogenic and non-pathogenic (%) | ||
| Household | 10 | 6 (60.00) | 4 (40.00) | 100 (100) |
| Small farm | 11 | 7 (63.64) | 4 (36.36) | 11 (100) |
| Overall | 21 | 13 (61.90) | 8 (38.10) | 21 (100) |
E. coli=Escherichia coli, PCR=Polymerase chain reaction
Antibiogram profile of E. coli and Salmonella spp. to different antimicrobials.
| Name of samples | Number of isolates tested | Number and percentage of microorganisms resistant to antimicrobials | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| AMX | AMP | AZM | ERY | NA | CIP | GM | TET | LEV | ||
| Oral swabs | 10 | 4 (40) | 6 (60) | 4 (40) | 5 (50) | 4 (40) | 0 (0) | 2 (20) | 7 (70) | 0 (0) |
| Cloacal swabs | 11 | 9 (81.81) | 9 (81.81) | 1 (9.09) | 8 (72.72) | 1 (9.09) | 0 (0) | 2 (18.18) | 4 (36.36) | 0 (0) |
| Total | 21 | 13 (61.90) | 15 (71.43) | 5 (23.81) | 13 (61.90) | 5 (23.81) | 0 (0) | 4 (19.05) | 11 (52.38) | 0 (0) |
| Oral swabs | 6 | 2 (33.33) | 2 (33.33) | 2 (33.33) | 3 (50) | 5 (83.33) | 0 (0) | 0 (0) | 6 (100) | 2 (33.33) |
| Cloacal swabs | 5 | 2 (40) | 1 (20) | 1 (20) | 2 (40) | 4 (80) | 0 (0) | 0 (0) | 5 (100) | 0 (0) |
| Total | 11 | 4 (36.36) | 3 (27.27) | 3 (27.27) | 5 (45.45) | 9 (81.82) | 0 (0) | 0 (0) | 11 (100) | 2 (18.18) |
AMX=Amoxicillin, AMP=Ampicillin, AZM=Azithromycin, ERY=Erythromycin, NA=Nalidixic acid, CIP=Ciprofloxacin, GM=Gentamicin, TET=Tetracycline, LEV=Levofloxacin, (zone diameter interpretive standard [mm] resistant ≤13, intermediate 14-17, susceptible ≥18), E. coli=Escherichia coli
Multidrug-resistant E. coli (n=21) and Salmonella spp. (n=11) isolated from pigeons.a
| Antimicrobial compound | Antibiotic class | Number of MDR isolates (%) |
|---|---|---|
| AMP, NA, GM | Pen-Qui-Ami | 1 (4.76) |
| AMP, AMX, GM | Pen-Bet-Ami | 1 (4.76) |
| AMP, AMX, NA, TET | Pen-Bet-Qui-Tet | 1 (4.76) |
| AMP, AMX, GM, TET | Pen-Bet-Tet-Ami | 1 (4.76) |
| AMP, NA, GM, TET | Pen-Qui-Tet-Ami | 1 (4.76) |
| Total | 5 (23.80) | |
| AMP, NA, TET | Pen-Qui-Tet | 2 (18.18) |
| AMX, NA, TET | Bet-Qui-Tet | 2 (18.18) |
| NA, TET, LEV | Qui-Tet-Flu | 1 (9.09) |
| AMP, NA, TET, LEV | Pen-Qui-Tet-Flu | 1 (9.09) |
| Total | 6 (54.54) |
MDR was calculated according to Magiorakos et al. [29]. Hence, macrolides are not included in MDR calculation. AMX=Amoxicillin, AMP=Ampicillin, AZM=Azithromycin, ERY=Erythromycin, NA=Nalidixic acid, CIP=Ciprofloxacin, GM=Gentamicin, TET=Tetracycline, LEV=Levofloxacin, Ami=Aminoglycosides, Pen=Penicillins, Tet=Tetracyclines, Bet=Beta-lactams, Qui=Quinolones, Flu=Fluoroquinolones, E. coli=Escherichia coli, MDR=Multidrug-resistant
Pairwise association of antibiotic resistance phenotypes in Escherichia coli (lower panel) and Salmonella spp. (upper panel) isolated from pigeon.a
| AMP | AMX | ERY | AZM | TET | NA | CIP | LEV | GEN | |
|---|---|---|---|---|---|---|---|---|---|
| AMP | 0.34 | 0.80 | 1.50 | 0.85 | 0.85 | 9.30 | 3.00 | 0.13 | |
| (0.03-3.93) | 0.04-17.20) | (0.14-16.55) | (0.02-50.11) | (0.02-50.11) | (0.35-252.47) | (0.26-35.34) | (0.01-1.10) | ||
| 0.40 | 0.89 | 0.75 | 0.94 | 0.94 | 0.19 | 0.39 | 0.15 | ||
| AMX | 81.67 | 0.17 | 3 | 1.19 | 1.19 | 0.11 | 0.34 | 8 | |
| (2.73-2447.57) | (0.01-4.36) | (0.26-35.34) | (0.020-69.99) | (0.020-69.99) | (0.01-2.93) | (0.03-3.93) | (0.51-127.91) | ||
| 0.01 | 0.28 | 0.39 | 0.94 | 0.94 | 0.19 | 0.39 | 0.15 | ||
| ERY | 5.28 | 3.89 | 1.25 | 3.80 | 3.80 | 1.67 | 0.11 | 4.10 | |
| (0.09-313.60) | (0.07-224.24) | (0.06-26.88) | (0.06-243.53) | (0.06-243.53) | (0.06-47.84) | (0.01-2.93) | (0.16-108.95) | ||
| 0.43 | 0.52 | 0.89 | 0.53 | 0.53 | 0.77 | 0.19 | 0.40 | ||
| AZM | 0.25 | 0.14 | 0.63 | 1.19 | 1.19 | 0.34 | 0.34 | 1.50 | |
| (0.02-3.35) | (0.02-1.68) | (0.02-34.83) | (0.02-69.98) | (0.02-69.98) | (0.03-3.93) | (0.03-3.93) | (0.14-16.55) | ||
| 0.30 | 0.13 | 0.83 | 0.94 | 0.94 | 0.39 | 0.39 | 0.75 | ||
| TET | 4 | 16 | 5.29 | 1.28 | 23 | 0.27 | 0.85 | 0.85 | |
| (0.24-66.77) | (0.96-267.05) | (0.09-313.60) | (0.09-16.81) | (0.19-2896.22) | (0.01-16.87) | (0.02-50.11) | (0.02-50.11) | ||
| 0.34 | 0.06 | 0.43 | 0.86 | 0.21 | 0.53 | 0.94 | 0.94 | ||
| NA | 0.47 | 0.34 | 3.89 | 2.10 | 0.47 | 0.27 | 0.85 | 0.85 | |
| (0.02-10.71) | (0.02-7.48) | (0.07-224.24) | (0.18-24.60) | (0.02-10.71) | (0.01-16.87) | (0.02-50.11) | (0.02-50.11) | ||
| 0.63 | 0.49 | 0.52 | 0.56 | 0.63 | 0.53 | 0.94 | 0.94 | ||
| CIP | 1.28 | 0.55 | 0.63 | 5.56 | 1.28 | 2.10 | 1.25 | 0.17 | |
| (0.10-16.81) | (0.07-4.92) | (0.02-34.83) | (0.81-38.17) | (0.10-16.81) | (0.18-24.60) | (0.06-26.88) | (0.01-4.36) | ||
| 0.86 | 0.59 | 0.83 | 0.08 | 0.86 | 0.56 | 0.89 | 0.28 | ||
| LEV | 0.20 | 0.11 | 0.52 | 3.34 | 0.05 | 6.43 | 1.35 | 0.13 | |
| (0.02-2.63) | (0.01-1.29) | (0.01-28.76) | (0.51-22.15) | (0.01-1.04) | (0.30-138.26) | (0.22-8.62) | (0.01-1.10) | ||
| 0.22 | 0.08 | 0.75 | 0.22 | 0.06 | 0.24 | 0.76 | 0.15 | ||
| GEN | 10.74 | 15.93 | 1.10 | 1.95 | 2.5 | 0.08 | 0.86 | 1.35 | |
| (0.49-238.92) | (0.74-345.09) | (0.02-60.30) | (0.33-11.76) | (0.20-32.81) | (0.01-1.71) | (0.15-5.0) | (0.22-8.62) | ||
| 0.14 | 0.08 | 0.97 | 0.47 | 0.49 | 0.11 | 0.87 | 0.76 |
Values in each cell: Before the parenthesis is odds ratio, within the parenthesis is 95% CI and after parenthesis is p value. AMP=Ampicillin, AMX=Amoxicillin, ERY=Erythromycin, AZM=Azithromycin, TET=Tetracycline, NA=Nalidixic acid, CIP=Ciprofloxacin, LEV=Levofloxacin, GM=Gentamicin, CI=Confidence interval